Editors
Current Atherosclerosis Reports
Editor-in-Chief
Antonio M. Gotto Jr, MD, DPhil (Weill Cornell Medical College, New York, New York, USA)
Associate Editor
Anders G. Olsson, MD, PhD (University Hospital, Linköping, Sweden)
Editorial Board
Jassim Al Suwaidi, MBChB, BAO, LRCP & SI (Hamad Medical Center, Doha, Qatar)
Gerd Assmann, MD (Institut fur Arterioskleroseforschung, Munster, Germany)
Jan Breslow, MD (Rockefeller University, New York, New York, USA)
Rafael Carmena, MD, PhD, FACP, FRCP (University of Valencia, Valencia, Spain)
Richard Ceska, MD,PhD, FEFIM (University General Hospital Prague, Prague, Czech Republic)
Ada Cuevas, Md, MSc (Clinica Las Condes, Santiago, Chile)
Jean-Charles Fruchart, PhD (Institute Pasteur de Lille, Lille, France)
David P. Hajjar, PhD (Weill Cornell Medical College, New York, New York, USA)
Jay Heinecke, MD (University of Washington, Seattle, Washington, USA)
Katsu Ikewaki, MD (Jikei University School of Medicine, Tokyo, Japan)
Eran Leitersdorf, MD (The Hebrew University of Jersusalem, Jerusalem, Israel)
Peter Libby, MD (Brigham and Women's Hospital, Boston, Massachusetts, USA)
Masunori Matsuzaki, PhD (Yamaguchi University, Yamaguchi, Japan)
Emilio Moriguchi, MD, PhD (Federal University of Rio Grande do Sul School of Medicine, Porte Alegre, Brazil)
Rodolfo Paoletti, MD, PhD (University of Milan, Milan, Italy)
Raul Santos, MD (University of São Paulo Medical Center, São Paulo, Brazil)
Attilio Rigotti, MD, PhD (Pontifical Catholic University of Chile, Santiago, Chile)
Alan R. Tall, MD (Columbia University College of Physicians and Surgeons, New York, New York, USA)
Lale Tokgözoglu, MD, FACC, FESC (Hacettepe University, Ankara, Turkey)
Andrew Tonkin, MD, FRACP (Monash University, Melbourne, Victoria, Australia)
Sections and Section Editors
Cardiometabolic Disease and Treatment
Raul Santos, MD, MSc, PhD (University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil)
Marcio Hiroshi Miname, MD, PhD (Heart Institute of University of Sao Paulo Medical School, Sao Paulo, Brazil)
Coronary Heart Disease
Salim Virani, MBBS, PhD (The Aga Khan University, Karachi, Pakistan)
Mahmoud Al Rifai, MD, PhD (Baylor College of Medicine, Houston, Texas, USA)
Evidence-Based Medicine, Clinical Trials and Their Interpretations
Khurram Nasir, MD MPH MSc (Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas, USA)
Sadeer Al-Kindi, MD, FACC (Houston Methodist, Houston, Texas, USA)
Nonstatin Drugs
Lale Tokgozoglu, MD, FACC, FESC (Hacettepe University, Ankara, Turkey)
Alberico L. Catapano, PhD (University of Milan, Milan Italy)
Genetics and Genomics
Robert A. Hegele, MD, FRCPC, FACP (University of Western Ontario, Robarts Research Institute, London, Ontario, Canada)
Liam Brunham, MD, PhD, FRCPC (University of British Columbia, Vancouver, British Columbia, Canada)
Nutrition
Reviews and Scientific Meetings and New Research Implications
Salim Virani, MBBS, PhD (The Aga Khan University, Karachi, Pakistan)
Statin Drugs
Richard Ceska, MD, PhD, FEFIM (University General Hospital Prague, Prague, Czech Republic)
Vascular Biology
Henry Pownall, PhD (Houston Methodist Research Institute, Houston, Texas, USA)
Women and Ischemic Heart Disease
Karol E. Watson, MD, PhD (David Geffen School of Medicine at UCLA, Los Angeles, California, USA)
Cardiovascular Disease and Stroke
James A. Underberg, MD (NYU Medical School, New York, New York, USA)
Michael Garshick, MD (NYU Grossman School of Medicine, New York, New York, USA)
Children/Adolescents/Young Adults and Atherosclerosis
Don P. Wilson, MD (Cook Children’s Medical Center, Fort Worth, Texas, USA)
Advancing Equity in Atherosclerosis
Jessica M. Peña, MD, MPH (Weill Cornell Medicine, New York, New York, USA)